Refractory/Relapsed Autoimmune Hemolytic Anemia
2 clinical trials · Condition
◉ Watch Refractory/Relapsed Autoimmune Hemolytic Anemia
| Record | Firm | Date |
|---|---|---|
| The Safety and Efficacy of Zanubrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia (NCT06021977) | Institute of Hematology & Blood Diseases Hospital, China | 2023-09-01 |
| The Safety and Efficacy of Ibrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia (NCT04398459) | Institute of Hematology & Blood Diseases Hospital, China | 2020-05-01 |
Track Refractory/Relapsed Autoimmune Hemolytic Anemia automatically
Every clearance here is in the API, with alerts when new ones post.